According to a new report Asia Pacific Burn Ointment Market, published by KBV research, the Asia Pacific Burn Ointment Market would witness market growth of 7% CAGR during the forecast period (2020-2026).
The China market dominated the Asia Pacific Hospitals Market by Country in 2019, and would continue to be a dominant market till 2026. The Japan market is exhibiting a CAGR of 7.5% during (2020 - 2026). Additionally, The India market is anticipated to grow at a CAGR of 7.5% during (2020 - 2026).
The Minor Burns market dominated the South Korea Burn Ointment Market by Depth of Burn in 2019. The Partial Thickness Burns market is expected to witness a CAGR of 7.8% during (2020 - 2026).
The Topical Antibiotics market dominated the Malaysia Burn Ointment Market by Product in 2019, thereby, achieving a market value of $5 Million by 2026. The Silver market is experiencing a CAGR of 8.4% during (2020 - 2026). Additionally, The Iodine market is estimated to grow at the highest CAGR of 8.6% during (2020 - 2026).
Full Report: https://www.kbvresearch.com/asia-pacific-burn-ointment-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Johnson and Johnson, ConvaTec Group PLC, Smith & Nephew PLC, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Perrigo Company PLC, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Morepen Limited and Mankind Pharma Ltd.
By Depth of Burn
By Product
By End Use
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
